In an all-encompassing vision of collagen action, it was observed that the cancer phenotype resulting from abnormal collagen production, which interferes with immunity activation acting as a barrier, overlap with phenotype resulting from ECM receptors signaling (i.e., LAIR-1 and Integrins) (Flies et al. 2023). Here, LAIR1 is linked to cancer.